Heart Failure Hospitalization (HFH) despite digoxin therapy versus no HFH despite placebo in the Digitalis Investigation Group (DIG) Trial: insights into risk factors for HFH in HF and Reduced Ejection Fraction (HFrEF).
Citation: Unpublished 2017/10/03Department: Medicine/General Internal MedicineForm of publication: Poster PresentationYear: 2017Conference information: MedStar Washington Hospital Center: MedStar Health Research Symposium, North Bethesda, MD., Fiscal year: FY2018Local accession number: A2017_016Date added to catalog: 2018-08-01| Item type | Current library | Collection | Call number | Status | Date due | Barcode |
|---|---|---|---|---|---|---|
| Poster Presentation | MedStar Authors Catalog | Poster | Available |